Objective: Estradiol (E2) acts to modulate the ratio of two dopamine D2 receptor isoforms (D2L/D2S) by the nuclear estrogen receptor (ER) and to reduce dopamine's inhibitory action on PRL secretion. Here we demonstrate the correlation between the expression of ER mRNA and D2R mRNA isoforms in pituitary neoplasms cells.

Methods: Twenty-four human pituitary adenomas (14 prolactinomas and 10 gonadotrope tumors) were examined for the expression of both ER mRNA and D2R mRNA by means of semi-quantitative RT-PCR analysis.

Results: No significant difference was found in ERbeta mRNA expression levels between prolactinomas and gonadotrope tumors (P = 0.871), but there was a significant difference in the expression of ERalpha mRNA (P = 0.003). The significant difference was found between the two pituitary adenomas types in both levels of D2S and D2L mRNA expression (P = 0.036 and 0.007 respectively). Furthermore, both levels of expression in prolactinomas were significantly higher than that in gonadotrope tumors. Additionally, a negative correlation between D2S and ERalpha mRNA expression and a positive correlation between D2L and ERalpha mRNA expression were found in these tumors.

Conclusion: This study for the first time shows a good correlation between expression of ER and D2R isoforms in prolactinomas and gonadotrope tumors. Reducing the amount of the ERalpha in neoplasm cells can alter the ratio of D2L/D2S, which may increase the drug sensitivity of pituitary adenomas.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9816-5DOI Listing

Publication Analysis

Top Keywords

gonadotrope tumors
20
prolactinomas gonadotrope
16
mrna expression
16
pituitary adenomas
12
eralpha mrna
12
mrna
11
expression
9
dopamine receptor
8
receptor mrna
8
estrogen receptor
8

Similar Publications

GnRH pulse generator activity in mouse models of polycystic ovary syndrome.

Elife

January 2025

Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom.

Article Synopsis
  • One in ten women of reproductive age have PCOS, characterized by subfertility, high LH levels, and potential dysfunction in the kisspeptin neurons that regulate GnRH.
  • Researchers studied the GnRH pulse generator in two mouse models of PCOS: the peripubertal androgen (PPA) model showed fewer synchronized neuron events, while the prenatal androgen (PNA) model revealed variable GnRH activity but cyclical patterns indicating complexity.
  • Findings indicate that in the PNA model, ARN neurons had increased activity during specific stages and less sensitivity to progesterone, highlighting the need to understand GnRH regulation in PCOS-related conditions.
View Article and Find Full Text PDF

Background: Pituitary neuroendocrine tumors (PitNET) are among the most common intracranial tumors. Despite a frequent benign course, aggressive behavior can occur. Tumor behavior is known to be under the influence of the tumor microenvironment (TME).

View Article and Find Full Text PDF

Background: In recent years, the incidence of gynecomastia in adult men has increased significantly. It is of interest to study the specific features of the disease in these patients.

Aim: To identify the main characteristics of acute gynecomastia in adult men.

View Article and Find Full Text PDF

Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists.

Pituitary

October 2024

Department of Endocrinology and Nutrition, Cliniques Universitaires Saint- Luc, 10 Avenue Hippocrate, Brussels, UCLouvain, 1200, Belgium.

Purpose: In men with prolactinoma treated with dopamine agonists (DA), the extent, timeline, and predictive factors of gonadotropic axis recovery are still unclear.

Methods: We analyzed data of 97 men with a prolactinoma treated with DA (77/97 macroprolactinomas). We excluded patients with primary hypogonadism, surgery < 12 months after DA initiation, and patients with tumors < 5 mm or prolactin < 45 µg/l at diagnosis.

View Article and Find Full Text PDF

Gonadal dysfunction, the most frequent endocrine complication in both sexes after autologous hematopoietic cell transplant (HCT) could increase bone loss and sarcopenia, a disease characterized by reduced muscle strength and mass. Sarcopenia is associated with worse survival, lower remission rates, and progression-free survival in patients with lymphoma after HCT. Low bone mass affected approximately 20% of the transplanted patients within 2 years and harms quality of life.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!